(Q44343579)

2 December 2017

title

Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children (English)

1 reference

2 December 2017

1 reference

1 reference

1 reference

1

Edmund V Capparelli

1 reference

2 December 2017

Janet A Englund

2

1 reference

2 December 2017

James D Connor

3

1 reference

2 December 2017

Stephen A Spector

4

1 reference

2 December 2017

Ross E McKinney

5

1 reference

2 December 2017

Paul Palumbo

6

1 reference

2 December 2017

Carol J Baker

7

1 reference

2 December 2017

language of work or name

1 reference

1 February 2003

1 reference

The Journal of Clinical Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

43

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

133-140

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Radioimmunoassay for Retrovir, an anti-human immunodeficiency virus drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Some suggestions for measuring predictive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Clinical pharmacokinetics of zidovudine. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Quantitative relationships between zidovudine exposure and efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

A general model for the origin of allometric scaling laws in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

A size standard for pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Population pharmacokinetics of zidovudine. The Veterans Administration Cooperative Studies Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

The pharmacokinetics of zidovudine administered by continuous infusion in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Concentration-controlled zidovudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

A sensitive nonisotopic method for the determination of intracellular azidothymidine 5′-mono-, 5′-di-, and 5′-triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239821

21 January 2018

Identifiers

DOI

10.1177/0091270002239821

1 reference

2 December 2017

1 reference